These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation. Norris PC; Skulas-Ray AC; Riley I; Richter CK; Kris-Etherton PM; Jensen GL; Serhan CN; Maddipati KR Sci Rep; 2018 Dec; 8(1):18050. PubMed ID: 30575798 [TBL] [Abstract][Full Text] [Related]
6. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Serhan CN; Libreros S; Nshimiyimana R Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568 [TBL] [Abstract][Full Text] [Related]
7. Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics. English JT; Norris PC; Hodges RR; Dartt DA; Serhan CN Prostaglandins Leukot Essent Fatty Acids; 2017 Feb; 117():17-27. PubMed ID: 28237084 [TBL] [Abstract][Full Text] [Related]
9. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS/MS. Hartling I; Cremonesi A; Osuna E; Lou PH; Lucchinetti E; Zaugg M; Hersberger M Clin Chem Lab Med; 2021 Oct; 59(11):1811-1823. PubMed ID: 34243224 [TBL] [Abstract][Full Text] [Related]
10. Cutting Edge: Human Vagus Produces Specialized Proresolving Mediators of Inflammation with Electrical Stimulation Reducing Proinflammatory Eicosanoids. Serhan CN; de la Rosa X; Jouvene CC J Immunol; 2018 Dec; 201(11):3161-3165. PubMed ID: 30355784 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and Changes in Lipid Mediator Profiling after Consumption of Specialized Pro-Resolving Lipid-Mediator-Enriched Marine Oil in Healthy Subjects. Irún P; Carrera-Lasfuentes P; Sánchez-Luengo M; Belio Ú; Domper-Arnal MJ; Higuera GA; Hawkins M; de la Rosa X; Lanas A Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003333 [TBL] [Abstract][Full Text] [Related]
13. Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus. Serhan CN; Chiang N Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S200-15. PubMed ID: 17965751 [TBL] [Abstract][Full Text] [Related]
14. The biosynthetic pathways of the protectins. Stenvik Haatveit Å; Hansen TV Prostaglandins Other Lipid Mediat; 2023 Dec; 169():106787. PubMed ID: 37806439 [TBL] [Abstract][Full Text] [Related]
15. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation. Serhan CN; de la Rosa X; Jouvene C J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762 [TBL] [Abstract][Full Text] [Related]
16. Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Serhan CN; Dalli J; Colas RA; Winkler JW; Chiang N Biochim Biophys Acta; 2015 Apr; 1851(4):397-413. PubMed ID: 25139562 [TBL] [Abstract][Full Text] [Related]